VWF Recombinant & Domain Proteins, Antibodies

Von Willebrand factor, or VWF, is a large multimeric glycoprotein produced primarily by vascular endothelial cells and megakaryocytes and plays a central role in primary hemostasis and coagulation. Following vascular injury, VWF interacts with exposed subendothelial components and platelet receptors to promote platelet adhesion and aggregation. VWF also binds coagulation factor VIII and protects it from rapid clearance in circulation. Structurally, VWF is composed of multiple functional domains whose coordinated activities regulate multimer formation, platelet interaction, collagen binding, proteolytic processing, and factor VIII stabilization. Quantitative or qualitative abnormalities in VWF can lead to bleeding disorders, whereas increased or dysregulated VWF activity is also relevant to thrombosis, inflammation, and vascular disease research. Its complex multidomain architecture makes VWF an important target for structural, functional, and protein-interaction studies.

DIMA BIOTECH provides human and mouse VWF recombinant proteins as well as proteins covering different functional regions of the molecule, together with rabbit monoclonal antibodies and conjugated reagent formats. Domain-specific proteins can be used for antibody screening, epitope mapping, functional-domain analysis, competitive binding, and protein-interaction studies. Multiple tag formats provide flexibility for ELISA, WB, SPR/BLI, and related assay platforms, while VWF antibodies support protein detection and immunoassay development. These tools provide a versatile resource for studying VWF structure-function relationships, coagulation biology, and assay development.